1. Home
  2. CXDO vs NKTX Comparison

CXDO vs NKTX Comparison

Compare CXDO & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CXDO
  • NKTX
  • Stock Information
  • Founded
  • CXDO 1995
  • NKTX 2015
  • Country
  • CXDO United States
  • NKTX United States
  • Employees
  • CXDO N/A
  • NKTX N/A
  • Industry
  • CXDO Telecommunications Equipment
  • NKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CXDO Telecommunications
  • NKTX Health Care
  • Exchange
  • CXDO Nasdaq
  • NKTX Nasdaq
  • Market Cap
  • CXDO 152.4M
  • NKTX 123.5M
  • IPO Year
  • CXDO 1998
  • NKTX 2020
  • Fundamental
  • Price
  • CXDO $6.29
  • NKTX $1.75
  • Analyst Decision
  • CXDO Strong Buy
  • NKTX Strong Buy
  • Analyst Count
  • CXDO 3
  • NKTX 6
  • Target Price
  • CXDO $8.50
  • NKTX $14.40
  • AVG Volume (30 Days)
  • CXDO 260.9K
  • NKTX 502.7K
  • Earning Date
  • CXDO 08-05-2025
  • NKTX 08-12-2025
  • Dividend Yield
  • CXDO N/A
  • NKTX N/A
  • EPS Growth
  • CXDO 51.44
  • NKTX N/A
  • EPS
  • CXDO 0.09
  • NKTX N/A
  • Revenue
  • CXDO $62,609,000.00
  • NKTX N/A
  • Revenue This Year
  • CXDO $12.98
  • NKTX N/A
  • Revenue Next Year
  • CXDO $10.91
  • NKTX N/A
  • P/E Ratio
  • CXDO $71.79
  • NKTX N/A
  • Revenue Growth
  • CXDO 13.85
  • NKTX N/A
  • 52 Week Low
  • CXDO $3.01
  • NKTX $1.31
  • 52 Week High
  • CXDO $7.34
  • NKTX $8.23
  • Technical
  • Relative Strength Index (RSI)
  • CXDO 67.60
  • NKTX 46.75
  • Support Level
  • CXDO $5.67
  • NKTX $1.63
  • Resistance Level
  • CXDO $6.04
  • NKTX $1.77
  • Average True Range (ATR)
  • CXDO 0.25
  • NKTX 0.08
  • MACD
  • CXDO 0.09
  • NKTX -0.01
  • Stochastic Oscillator
  • CXDO 89.53
  • NKTX 34.78

About CXDO Crexendo Inc.

Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: